AGGARWAL SUMIT (PRESIDENT AND CEO) received a stock award from ELOXX PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/17/2024ACC: 0001104659-24-109519
DirectorOfficer· PRESIDENT AND CEO
Since Apr 2021
+165K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
165K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+165K
Price / share
—
Trade value
—
% of position
3346.9%
10/16/2024
4.93K→169.93K
Total
Net shares
+165K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/16/2024 | A · Award | +165K | — | — | 3346.9% | 4.93K | 169.93K |
| Total | +165K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported